Treatment with E2 (10, 50, 100 nm) induced the expression of estrogen receptor α (ERα), led to the activation of the Gα13-RhoA-ROCK-2-MSN signaling pathway, which resulted in the upregulation of MSN expression in endometriosis (Figure 3C). Here, MSN is linked to endometriosis.